Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms

Correlation of GSTP1 gene variants of male Iraqi waterpipe (Hookah) tobacco smokers and the risk of lung cancer

(2020) Bassam K. Kudhair et al.   MOLECULAR BIOLOGY REPORTS

Glutathione S-Transferase P1 Polymorphism on Exon 6 and Risk of Hepatocellular Carcinoma in Thai Male Patients

(2020) Thanet Sophonnithiprasert et al.   ONCOLOGY

The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice

(2020) Anouk KM Claessens et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

GSTP1 rs1138272 Polymorphism Affects Prostate Cancer Risk

(2020) Veljko Santric et al.   Medicina-Lithuania

The Synergistic Antitumor Effect of 5-Fluorouracil Combined with Allicin against Lung and Colorectal Carcinoma Cells

(2020) Adrian Bogdan Țigu et al.   MOLECULES

Genistein combined with FOLFOX or FOLFOX–Bevacizumab for the treatment of metastatic colorectal cancer: phase I/II pilot study

(2019) Sofya Pintova et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Functional Characterization of 21 Allelic Variants of Dihydropyrimidine Dehydrogenase Identified in 1070 Japanese Individuals

(2018) Eiji Hishinuma et al.   DRUG METABOLISM AND DISPOSITION

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Cancer statistics in China, 2015

(2016) Wanqing Chen et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time

(2016) Carin A.T.C. Lunenburg et al.   EUROPEAN JOURNAL OF CANCER

Pharmacogenetic and ethnicity influence on oxaliplatin therapy for colorectal cancer: a meta-analysis

(2016) Adel Shahnam et al.   PHARMACOGENOMICS

Germline TYMS genotype is highly predictive in patients with metastatic gastrointestinal malignancies receiving capecitabine-based chemotherapy

(2015) M. Joerger et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Improved determination of uracil and dihydrouracil in plasma after a loading oral dose of uracil using high-performance liquid chromatography with photodiode array detection and porous graphitic carbon stationary phase

(2015) Roberta Zilles Hahn et al.   CLINICAL BIOCHEMISTRY

The Combination of the PARP Inhibitor Rucaparib and 5FU Is an Effective Strategy for Treating Acute Leukemias

(2015) M. V. V. Falzacappa et al.   MOLECULAR CANCER THERAPEUTICS

The GSTP1 A1578G polymorphism and the risk of childhood acute lymphoblastic leukemia: results from an updated meta-analysis

(2013) G.Z. Huang et al.   GENETICS AND MOLECULAR RESEARCH

Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery

(2012) Salvatore Terrazzino et al.   RADIOTHERAPY AND ONCOLOGY

Relationship between Single Nucleotide Polymorphisms and Haplotypes in DPYD and Toxicity and Efficacy of Capecitabine in Advanced Colorectal Cancer

(2011) M. J. Deenen et al.   CLINICAL CANCER RESEARCH

Dihydropyrimidine dehydrogenase gene as a major predictor of severe 5-fluorouracil toxicity

(2011) Ursula Amstutz et al.   PHARMACOGENOMICS

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741

(2010) Howard L. McLeod et al.   JOURNAL OF CLINICAL ONCOLOGY

Relationship between GSTP1 Ile105Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity

(2009) O. Mir et al.   ANNALS OF ONCOLOGY

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

(2008) M. Borner et al.   ANNALS OF ONCOLOGY